These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28982898)

  • 21. Prognostic value of complete response in patients with muscle-invasive bladder cancer undergoing concurrent chemoradiotherapy.
    Wu CE; Lin YC; Hong JH; Chuang CK; Pang ST; Liaw CC
    Anticancer Res; 2013 Jun; 33(6):2605-10. PubMed ID: 23749915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified Glasgow prognostic score can predict survival of muscle invasive bladder cancer patients after radiotherapy.
    Kikuchi K; Nakamura R; Segawa T; Oikawa H; Ariga H
    J Radiat Res; 2020 Jul; 61(4):616-621. PubMed ID: 32567660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of acute toxicity and symptoms palliation in a hypofractionated weekly schedule of external radiotherapy for elderly patients with muscular invasive bladder cancer.
    Kouloulias V; Tolia M; Kolliarakis N; Siatelis A; Kelekis N
    Int Braz J Urol; 2013; 39(1):77-82. PubMed ID: 23489500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer.
    Fokdal L; Høyer M; von der Maase H
    Acta Oncol; 2004; 43(8):749-57. PubMed ID: 15764221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muscle-invasive bladder cancer in elderly-unfit patients with concomitant illness: can a curative radiation therapy be delivered?
    Santacaterina A; Settineri N; De Renzis C; Frosina P; Brancati A; Delia P; Palazzolo C; Romeo A; Sansotta G; Pergolizzi S
    Tumori; 2002; 88(5):390-4. PubMed ID: 12487557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors for survival in patients with recurrence of muscle invasive bladder cancer after treatment with curative intent.
    Ploeg M; Kums AC; Aben KK; van Lin EN; Smits G; Vergunst H; Viddeleer AC; Geboers AD; van Berkel H; van Boven E; Kiemeney LA; Witjes F
    Clin Genitourin Cancer; 2011 Sep; 9(1):14-21. PubMed ID: 21723794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
    Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
    Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical results of conformal versus intensity-modulated radiotherapy using a focal simultaneous boost for muscle-invasive bladder cancer in elderly or medically unfit patients.
    Lutkenhaus LJ; van Os RM; Bel A; Hulshof MC
    Radiat Oncol; 2016 Mar; 11():45. PubMed ID: 26993980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome.
    Zilli T; Jorcano S; Escudé L; Linero D; Rouzaud M; Dubouloz A; Miralbell R
    Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):316-22. PubMed ID: 24667210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organ-sparing treatment in muscle-invasive bladder cancer.
    Dunst J; Diestelhorst A; Kühn R; Müller AC; Scholz HJ; Fornara P
    Strahlenther Onkol; 2005 Oct; 181(10):632-7. PubMed ID: 16220401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of combined method in organ-sparing treatment of muscle-invasive bladder cancer recurrences.
    Startsev VY
    Arch Ital Urol Androl; 2002 Jun; 74(2):54-6. PubMed ID: 12161935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Curative Radiotherapy in Elderly Patients With Muscle Invasive Bladder Cancer: The Prognostic Role of Sarcopenia.
    Ferini G; Cacciola A; Parisi S; Lillo S; Molino L; Tamburella C; Davi V; Napoli I; Platania A; Settineri N; Iati G; Pontoriero A; Pergolizzi S; Santacaterina A
    In Vivo; 2021; 35(1):571-578. PubMed ID: 33402511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radical cystectomy in the treatment of bladder cancer always in due time?].
    May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
    Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience.
    Efstathiou JA; Spiegel DY; Shipley WU; Heney NM; Kaufman DS; Niemierko A; Coen JJ; Skowronski RY; Paly JJ; McGovern FJ; Zietman AL
    Eur Urol; 2012 Apr; 61(4):705-11. PubMed ID: 22101114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer.
    Miyata H; Osawa T; Abe T; Kikuchi H; Matsumoto R; Maruyama S; Nishioka K; Shimizu S; Hashimoto T; Shirato H; Shinohara N
    Jpn J Clin Oncol; 2020 May; 50(5):609-616. PubMed ID: 31955206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study.
    Orré M; Latorzeff I; Fléchon A; Roubaud G; Brouste V; Gaston R; Piéchaud T; Richaud P; Chapet O; Sargos P
    PLoS One; 2017; 12(4):e0174978. PubMed ID: 28384195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Online adaptive radiotherapy for muscle-invasive bladder cancer: results of a pilot study.
    Foroudi F; Wong J; Kron T; Rolfo A; Haworth A; Roxby P; Thomas J; Herschtal A; Pham D; Williams S; Tai KH; Duchesne G
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):765-71. PubMed ID: 20932678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients.
    Koga F; Numao N; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    Urol Oncol; 2013 Oct; 31(7):1270-5. PubMed ID: 22386622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein level predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy.
    Yoshida S; Saito K; Koga F; Yokoyama M; Kageyama Y; Masuda H; Kobayashi T; Kawakami S; Kihara K
    BJU Int; 2008 Apr; 101(8):978-81. PubMed ID: 18190628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.